International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder-Reference-Cited by-同舟云学术

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

Published:2018 Issue:1 Volume:24 Page:43-51
ISSN:1022-6877
Container-title:European Addiction Research
language:en
Short-container-title:Eur Addict Res

Author:

Crunelle Cleo L.^ORCID,van den Brink Wim,Moggi Franz^ORCID,Konstenius Maija,Franck Johan^ORCID,Levin Frances R.,van de Glind Geurt,Demetrovics Zsolt^ORCID,Coetzee Corné,Luderer Mathias^ORCID,Schellekens Arnt,Matthys Frieda,

Publisher

S. Karger AG

Subject

Psychiatry and Mental health,Health(social science),Medicine (miscellaneous)

Reference47 articles.

1. Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MW, Demetrovics Z, Kapitány-Fövény M, Schoevers RA, van Emmerik-van Oortmerssen K, Carpentier PJ, Dom G, Verspreet S, Crunelle CL, Young JT, Carruthers S, Cassar J, Fatséas M, Auriacombe M, Johnson B, Dunn M, Slobodin O, van den Brink W: Persistence and dubtype stability of ADHD among substance use disorder treatment seekers. J Atten Disord 2016;pii:1087054716629217.

2. Fatséas M, Hurmic H, Serre F, Debrabant R, Daulouède JP, Denis C, Auriacombe M: Addiction severity pattern associated with adult and childhood attention deficit hyperactivity disorder (ADHD) in patients with addictions. Psychiatry Res 2016; 246: 656–662.

3. Young JT, Carruthers S, Kaye S, Allsop S, Gilsenan J, Degenhardt L, van de Glind G, van den Brink W, Preen D: Comorbid attention deficit hyperactivity disorder and substance use disorder complexity and chronicity in treatment-seeking adults. Drug Alcohol Rev 2015; 34: 683–693.

4. van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitány-Fövény M, Kaye S, Konstenius M, Levin FR, Moggi F, Møller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S; IASP research group, van den Brink W, Schoevers RA: Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction 2014; 109: 262–272.

5. Levin FR, Evans SM, Vosburg SK, Horton T, Brooks D, Ng J: Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav 2004; 29: 1875–1882.

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review;Current Neuropharmacology;2024-09

2. Prevalence and clinical phenotypes of adult patients with attention deficit hyperactivity disorder and comorbid behavioral addictions;Journal of Behavioral Addictions;2024-06-26

3. Attention Deficit Hyperactivity Disorder: A Risk Factor for Premature Discontinuation of Inpatient Opioid Withdrawal Treatment;Journal of Clinical Medicine;2024-06-03

4. Impact of Treatment with Central Nervous System Stimulant and Risk of Substance Use Disorder in Adults with Attention-Deficit/Hyperactivity Disorder;International Journal of Mental Health and Addiction;2024-05-28

5. Cannabisarzneimittel in der Behandlung psychischer Störungen – Befunde aus der Cannabis-Begleiterhebung des Bundesinstituts für Arzneimittel und Medizinprodukte;Psychiatrische Praxis;2024-05-15